Teva Pharmaceuticals
TEVA
TEVA
449 hedge funds and large institutions have $4.12B invested in Teva Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 77 funds opening new positions, 126 increasing their positions, 137 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
less ownership
Funds ownership: →
8% less repeat investments, than reductions
Existing positions increased: 126 | Existing positions reduced: 137
9% less call options, than puts
Call options by funds: $345M | Put options by funds: $380M
20% less capital invested
Capital invested by funds: $5.14B → $4.12B (-$1.02B)
Holders
449
Holding in Top 10
6
Calls
$345M
Puts
$380M
Top Buyers
| 1 | +$135M | |
| 2 | +$122M | |
| 3 | +$34.6M | |
| 4 |
Citigroup
New York
|
+$32.7M |
| 5 |
MMH
Menora Mivtachim Holdings
Ramat Gan,
Israel
|
+$31M |
Top Sellers
| 1 | -$417M | |
| 2 | -$60.2M | |
| 3 | -$20.3M | |
| 4 |
BMO
Beck Mack & Oliver
New York
|
-$16.9M |
| 5 |
IAM
Ion Asset Management
Herzliya,
Israel
|
-$15.9M |